LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Search

Zimmer Biomet Holdings Inc

Suletud

SektorTervishoid

83.67 1.3

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

82.47

Max

84.22

Põhinäitajad

By Trading Economics

Sissetulek

99M

239M

Müük

-157M

2.1B

P/E

Sektori keskmine

20.617

51.415

Aktsiakasum

2.09

Dividenditootlus

1.17

Kasumimarginaal

11.43

Töötajad

17,000

EBITDA

84M

538M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+17.36% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.17%

2.34%

Järgmine tulemuste avaldamine

6. aug 2026

Järgmine dividendimakse kuupäev

30. juuli 2026

Järgmine aktsia dividendi kuupäev (ex-date)

25. juuni 2026

Turustatistika

By TradingEconomics

Turukapital

-2.5B

15B

Eelmine avamishind

82.37

Eelmine sulgemishind

83.67

Uudiste sentiment

By Acuity

39%

61%

122 / 345 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. nov 2025, 19:38 UTC

Tulu

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5. nov 2025, 17:00 UTC

Tulu

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Zimmer Biomet Holdings Inc Prognoos

Hinnasiht

By TipRanks

17.36% tõus

12 kuu keskmine prognoos

Keskmine 97.08 USD  17.36%

Kõrge 109 USD

Madal 83 USD

Põhineb 16 Wall Streeti analüütiku instrumendi Zimmer Biomet Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

16 ratings

4

Osta

11

Hoia

1

Müü

Tehniline skoor

By Trading Central

92.27 / 100.88Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Sentiment

By Acuity

122 / 345 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat